These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 18599083)
1. The novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin, prevents local and remote organ injury following intestinal ischemia/reperfusion in rats. Suzuki T; Yamashita K; Jomen W; Ueki S; Aoyagi T; Fukai M; Furukawa H; Umezawa K; Ozaki M; Todo S J Surg Res; 2008 Sep; 149(1):69-75. PubMed ID: 18599083 [TBL] [Abstract][Full Text] [Related]
2. Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin. Ueki S; Yamashita K; Aoyagi T; Haga S; Suzuki T; Itoh T; Taniguchi M; Shimamura T; Furukawa H; Ozaki M; Umezawa K; Todo S Transplantation; 2006 Dec; 82(12):1720-7. PubMed ID: 17198266 [TBL] [Abstract][Full Text] [Related]
3. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo. Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200 [TBL] [Abstract][Full Text] [Related]
4. Effect of a small molecule inhibitor of nuclear factor-kappaB nuclear translocation in a murine model of arthritis and cultured human synovial cells. Wakamatsu K; Nanki T; Miyasaka N; Umezawa K; Kubota T Arthritis Res Ther; 2005; 7(6):R1348-59. PubMed ID: 16277688 [TBL] [Abstract][Full Text] [Related]
5. Influence of Ketotifen, Cromolyn Sodium, and Compound 48/80 on the survival rates after intestinal ischemia reperfusion injury in rats. Hei ZQ; Gan XL; Huang PJ; Wei J; Shen N; Gao WL BMC Gastroenterol; 2008 Sep; 8():42. PubMed ID: 18808687 [TBL] [Abstract][Full Text] [Related]
6. Nuclear factor-kappaB inhibition by pyrrolidinedithiocarbamate attenuates gastric ischemia-reperfusion injury in rats. El Eter E; Hagar HH; Al-Tuwaijiri A; Arafa M Can J Physiol Pharmacol; 2005 Jun; 83(6):483-92. PubMed ID: 16049548 [TBL] [Abstract][Full Text] [Related]
7. Potent cytotoxic effect of a novel nuclear factor-kappaB inhibitor dehydroxymethylepoxyquinomicin on human bladder cancer cells producing various cytokines. Kodaira K; Kikuchi E; Kosugi M; Horiguchi Y; Matsumoto K; Kanai K; Suzuki E; Miyajima A; Nakagawa K; Tachibana M; Umezawa K; Oya M Urology; 2010 Apr; 75(4):805-12. PubMed ID: 20156648 [TBL] [Abstract][Full Text] [Related]
8. Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, prevents inflammatory injury induced by interferon-gamma and histamine in NCTC 2544 keratinocytes. Cardile V; Libra M; Caggia S; Frasca G; Umezawa K; Stivala F; Mazzarino MC; Bevelacqua Y; Coco M; Malaponte G Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):679-83. PubMed ID: 20337659 [TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibition attenuates lung injury induced by intestinal ischemia reperfusion in rats. Tian XF; Zhang XS; Li YH; Wang ZZ; Zhang F; Wang LM; Yao JH Life Sci; 2006 Oct; 79(22):2069-76. PubMed ID: 16875703 [TBL] [Abstract][Full Text] [Related]
10. Effects of tempol, a membrane-permeable radical scavenger, on local and remote organ injuries caused by intestinal ischemia/reperfusion in rats. Teke Z; Kabay B; Ozden A; Yenisey C; Bir F; Demirkan NC; Bicakci T; Erdem E J Surg Res; 2008 Oct; 149(2):259-71. PubMed ID: 18533188 [TBL] [Abstract][Full Text] [Related]
11. Activation of NF-κB pathway in oral buccal mucosa during small intestinal ischemia-reperfusion injury. Kim SI; Kim YB; Koh KM; Youn YK; Suh GJ; Cho ES; Leem DH; Baek JA; Shin HK; Ko SO J Surg Res; 2013 Jan; 179(1):99-105. PubMed ID: 22985774 [TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibitor lactacystin ablates liver injury induced by intestinal ischaemia-reperfusion. Yao JH; Li YH; Wang ZZ; Zhang XS; Wang YZ; Yuan JC; Zhou Q; Liu KX; Tian XF Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1102-8. PubMed ID: 17880361 [TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cells. Horiguchi Y; Kuroda K; Nakashima J; Murai M; Umezawa K Expert Rev Anticancer Ther; 2003 Dec; 3(6):793-8. PubMed ID: 14686701 [TBL] [Abstract][Full Text] [Related]
15. Effects of a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), on growth, apoptosis, gene expression, and chemosensitivity in head and neck squamous cell carcinoma cell lines. Ruan HY; Masuda M; Ito A; Umezawa K; Nakashima T; Yasumatsu R; Kuratomi Y; Yamamoto T; Weinstein IB; Komune S Head Neck; 2006 Feb; 28(2):158-65. PubMed ID: 16355386 [TBL] [Abstract][Full Text] [Related]
16. Pyrrolidine dithiocarbamate prevents 60 minutes of warm mesenteric ischemia/reperfusion injury in rats. Teke Z; Kabay B; Aytekin FO; Yenisey C; Demirkan NC; Sacar M; Erdem E; Ozden A Am J Surg; 2007 Aug; 194(2):255-62. PubMed ID: 17618816 [TBL] [Abstract][Full Text] [Related]
17. Immediate but not delayed postconditioning during reperfusion attenuates acute lung injury induced by intestinal ischemia/reperfusion in rats: comparison with ischemic preconditioning. Liu KX; Li YS; Huang WQ; Li C; Liu JX; Li Y J Surg Res; 2009 Nov; 157(1):e55-62. PubMed ID: 19345372 [TBL] [Abstract][Full Text] [Related]
18. The role of tumor necrosis factor-alpha and interleukin-1beta in ischemia-reperfusion injury of the rat small intestine. Yamamoto S; Tanabe M; Wakabayashi G; Shimazu M; Matsumoto K; Kitajima M J Surg Res; 2001 Jul; 99(1):134-41. PubMed ID: 11421615 [TBL] [Abstract][Full Text] [Related]
19. Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine. Arumugam TV; Shiels IA; Woodruff TM; Reid RC; Fairlie DP; Taylor SM J Surg Res; 2002 Apr; 103(2):260-7. PubMed ID: 11922743 [TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism. Lampiasi N; Azzolina A; D'Alessandro N; Umezawa K; McCubrey JA; Montalto G; Cervello M Mol Pharmacol; 2009 Aug; 76(2):290-300. PubMed ID: 19461054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]